Frontlight ResearchEarly access
Trial site
David H. Koch Center for Cancer Care at Memorial Sloan Kettering
- 2running trials
The trials here
What the 2 trials at this site are about, from their registry records.
- Conditions
- Chronic myeloid leukaemia1 trial
- Myeloproliferative neoplasms1 trial
- Phase
- Phase 11 trial
- Phase 21 trial
- Status
- Active, not recruiting1 trial
- Recruiting1 trial
- Lead sponsor
- Ajax Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company1 trial
- H. Lee Moffitt Cancer Center and Research Institute1 trial
Running trials
Recruiting
Active, not recruiting
Treatment Free Remission After Combination Therapy With Ruxolitinib Plus Tyrosine Kinase Inhibitors
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Myeloproliferative neoplasms1 recruiting
Site data: ClinicalTrials.govUpdated 12 Nov 2026